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2 Introduction  
 
The treatment of hyperglycaemia is crucial in the 
management of metabolic syndromes such as type II 
diabetes. The α-amylase, and α-glucosidase as digestive 
enzymes have an essential role in glucose release taking 
part in dietary polysaccharides hydrolysis. These enzymes 
have important role in diabetes research, because they are 
potential targets for antidiabetic drug research. It is a 
commonly accepted strategy to manage hyperglycaemia 
by the inhibition of α-amylase and α-glucosidase. The 
inhibition of these enzymes postpones remarkably the 
adsorption of glucose along with the postprandial 
hyperglycaemia. The acarbose is widely applied 
antidiabetic drug that inhibit pancreatic α-amylase and 
intestinal α-glucosidase. Although it is very effective, but 
it has several unpleasant gastrointestinal side effects. This 
is the reason that there is an increased demand for new 
molecules possessing less side effects. Several clinical 
studies, dealing with the postprandial glycaemic 
investigations, have demonstrated the effectiveness of the 
food polyphenols in the treatment of high blood glucose 
levels. The berries are rich in these compounds that wild 
strawberry, bilberry and blueberry were chosen to study 





Nowadays, the type II diabetes is the most commonly 
occurring disorder in civilisation, which could be treat 
successfully using medicinal herbs. To facilitate the 
possibility of practical applicability of the medicinal herbs 
the aims of my PhD thesis were the followings:  
1. Preparation of several medicinal herbs extracts 
containing bioactive components and assay of their 
in vitro anti-diabetic activities. 
2. Development of a novel HPLC method for the 
measurement of in vitro α-amylase activities.  
3. Determine the effects on cells of the selected 
medicinal plant extracts using cell lines.  
4. Mapping the possible bioactive components with 
mass spectrometric investigations.  
5. Testing of the herb extracts in vivo in STZ induced 
and HFHS diet treated diabetic rats. 
 
 
4 Materials and methods 
 
1. Sample preparation procedures: 
a. Selection of plants, aquatic extraction of 
herbs and lyophilization. 
b. Tannin precipitation from the plant 
extracts. 
2. Examination of the effect of plant extracts on the 
glycoside-hydrolase enzymes.  
a. Development of HPLC method for the 
measurement of α-amylase inhibition, 
synthesis and purification of the substrate.  
b. Determination of α-amylase inhibition of 
the plant extracts using the developed 
method. 
c. Determination of α-glycosidase inhibition 
of the plant extracts with 
spectrophotometric method. 
3. Measurement of the antioxidant capacity of the 
plant extract.  
4. Investigation of the extracts with mass 
spectrometric technique (MALDI-TOF).  
5. Cell based bioactivity assays: 
a. Cytotoxicity assay on H9c2 cells 
b. Cytoprotecting assay with RTCA-SP 
system. 
6. In vivo assays: 
a. Applying of chemically induced diabetes 
model for the test of extracts. 
b. Applying of HFHS dietic induced model 






5.1 Development of α-amylase inhibition 
measurement method 
 
During the method development the 2-chloro-4-
nitrophenyl-β-D-maltoheptaoside (CNP-G7) substrate 
was synthetized, which was purified via preparative 
chromatographic technique. The purity of the final product 
was checked with liquid chromatography showing the 
retention time for CNPG-7 6.7 min and for purity 96.9%. 
For the comprehensive confirmation of our results mass 
spectrometric examinations were also carried out in 
positive ionization mode with MALDI-TOF MS 
technique. The m/z values of potassium and sodium 
adducts characteristics for the CNPG-7 appeared in the 





5.2 Effects of plant extracts to the glycoside-
hydrolase enzymes 
 
During the pretreatment the aquatic extraction of 
plant material was carried out followed by lyophilization. 
The dried plant samples were dissolved in water and after 
the centrifugation their effects on both α-amylase and α-
glucosidase were determined. After the measurements 
three plants were selected with the 8.84±2.8 µg/ml, 25±8 
µg/ml and 27.27±9 µg/ml IC50 values for wild strawberry, 
blueberry and blackberry, respectively. The effects of the 
mixture created from these plants in equal ratio was also 
tested and the observed IC50 values were 11.2 µg/ml and 
15.3 µg/ml in the case of α-glucosidase and α-amylase, 
respectively.  
The enzyme inhibition examinations were also 
carried out after the precipitation of tannins from the 
mixture causing only 7.2% and 14.9% loss of the original 
inhibition values for α-amylase and α-glucosidase, 
respectively. However, the observed inhibition values 
remained at high level, thus it could be concluded that the 
inhibition caused not only from the tannin content.  
5.3 Antioxidant capacity of the selected plant 
extracts 
 
The abilities of the plant metabolites to inhibit the 
releasing of free radicals and the connected harmful side 
effects termed as antioxidant capacity. The measurement 
of antioxidant capacity were carried out in each plant 
extract. The C-vitamin equivalent antioxidant capacities of 
blueberry, wild strawberry and blackberry were 
809.15±68.27 µg/mg, 490.47±56.97 µg/mg and 
366.32±42.67 µg/mg, respectively. 
 
5.4 Mass spectrometric analysis of the selected plant 
extract 
 
During the measurement of the plant extracts, the 
metabolites were identified in the samples based on their 
kationized – protonated, potassium and/or sodium adducts 
– quasi molecular ions. If all of three molecular ions were 
detected including m/z values of [M+H]+, [M+K]+ and 
[M+Na]+ , the chemical composition s were detected with 
the Metabolomics Workbench Databank. Remarkable part 
of the detected metabolites is belonging to the group of 
flavonoids, whose biological activities are known from 
more aspects. 
 
5.5 Cytotoxic and citoprotective effects of the 
selected plant extracts 
 
The possible cytotoxic effects of the plant extracts 
were tested by MTT-assay, while the cytoprotective 
effects were measured with real-time cell electronic 
sensing system (RT-CES) using H9c2 embryonal rat heart 
cell lines. According to the results of the performed 
examinations, it could be concluded that the applied plant 
extracts cannot be considered toxic in the used in vitro 
setup. However, in the cytoprotection experiments the 
harmful effects of the hydrogen-peroxide as stressor could 
not be protected via none of the extracts. 
 
5.6 Analysis of the extracts in in vivo diabetes mice 
model  
 
For the first in vivo model STZ induced CD1mice 
were used. Five days after the STZ treatment, the blood 
glucose level was significantly improved due to the starch 
administration. The effects of both the acarbose and plant 
extract treated mice were similar, because in both cases the 
blood glucose concentrations reduced. For further diabetic 
mice model C57B16 mice were used. This type of mice 
susceptible to diet induced obesity. The control group for 
type II diabetes model had the same age and fed with 
normal diet. This experimental group showed no 
difference after administration of starch and plant extracts 
or acarbose. The starting blood glucose level of this group 
were notably lower compared to the diabetic mice. After 
administration of starch followed by acarbose or plant 
extract the blood glucose level remained stable throughout 




1. Eight plants were selected based on literature 
whose glycoside-hydrolase activity were teted in 
vitro. The plant extracts inhibited the α-amylase 
with dose dependent manner. The related IC50 
value of each plants were determined. The 
strawberry extract showed the lowest value while 
the IC50 value of blueberry and raspberry were 
significantly higher.  
 
2. Novel HPLC method was developed for the 
sensitive analysis of α-amylase. The application of 
HPLC makes it possible to separate components 
and analyse their quantity as well as the reaction 
rate could be calculated. A new synthetic substrate 
was applied that forms stronger bonds with the 
active centrum of amylase, consequently it models 
well the natural environments. The gained β-
configuration within the synthesis defend the 
substrate against the cleavage of amylase, thus the 
chromophore group remains on the substrate 
causing the specificity of the detection. The purity 
of the substrate was determined by liquid 
chromatography and MALDI-TOF MS.  
3. Before the animal experiments to check the effects 
of the plant extracts on cells in vitro cytotoxic and 
cytoprotecting tests were applied.  The results 
showed that none of the examined plant had any 
cytotoxic effect in the investigated concentrations 
range.  
4. The components of plants were analysed with mass 
spectrometric methods. Using the MALDI-TOF 
MS results, the formula of a lot of compound were 
determined and their potential names were 
determined according to the literature. Based on 
the results the extracts contained high amount of 
polyphenolic substances, from which the most 
important could be the tannins, ellagic tannins, 
flavonoids and its derivatives.  
5. During in vivo experiments the plant extracts were 
tested in both diabetic mice models. The 
chemically induced diabetes model is an easy and 
cost-effective method for studying the 
pathogenesis of type I diabetes, thus this method 
was applied on CD1 mice with STZ induction. To 
test the model type II diabetes, HFHS diet induced, 
pre-diabetic obese model was applied. For these 
experiments, C57BL6 mice were used that are 
susceptible to the diet induced diabetic conditions. 
In both models the blood glucose level was 
examined by tail blood. The results showed that the 
applied plant extracts effectively attenuate 
postprandial hyperglycaemia in normal and pre-
diabetic as well as STZ induced mice. The 
utilization of mixture of the extracts of the three 
plants confirmed the applicability of these plants in 
the treatment of the postprandial hyperglycaemia 
by the inhibition of α-amylase and α-glucosidase. 
Furthermore, it could be used safely, because none 
of cytotoxic effects were observed. The results of 
our study suggests, involving the in vitro and in 
vivo examinations, that the anti-hyperglycaemic 
effect of the plant extracts are in correlation with 
the inhibition of α-amylase and α-glucosidase. The 
extracts are not toxic and there are no obvious side-
effects, consequently it can be aimed as 
complementer treatment of type II diabetes or 
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